Broad Institute

Responding to COVID19

Learn how the Broad community is contributing to the global pandemic response

Promoting inclusion

Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity

Sharing data and knowledge

Broad Institute is committed to making the extensive data, methods, and technologies it generates rapidly and readily accessible to the scientific community to drive biomedical progress around the world

Building partnerships

Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer

Empowering scientists

Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential

Reaching globally

Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries

Collaborating deeply

Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world

Propelling the understanding and treatment of disease

Broad Institute of MIT and Harvard is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease

INSIDE BROAD

News / 03.4.21

Massive single-cell study suggests biological roots of COVID-19 risk factors

Human Cell Atlas researchers found cells vulnerable to viral infection in a wide range of tissues in the bodyRead more

News / 02.25.21

Broad Institute is processing pooled COVID-19 tests for Massachusetts K-12 schools

Here’s more on how pooled testing works, and what students and parents can expect.Read more

News / 03.8.21

New single-cell technology points to mechanism of cancer immunotherapy resistance

Researchers used Perturb-CITE-seq to identify a protein involved in resistance to immune checkpoint inhibitors.Read more

News / 02.23.21

Online tool tracks mutations in COVID-19 virus

COVID CG can help scientists monitor SARS-CoV-2’s evolution around the world and inform vaccine and therapeutics development.Read more

News / 02.22.21

The Broad’s new Gene Regulation Observatory will take the most detailed look yet at the non-coding genome

Observatory scientists will build models to predict the function of all regulatory elements in the human genome and collate an atlas for genome science and medicineRead more

News / 03.5.21

Research Roundup: March 5, 2021

Molecular roots of COVID-19 susceptibility, cells' nutrients affect CRISPR screens, understanding prostate cancer resistance, and moreRead more

News / 02.22.21

A call to action to build a better map of cancer’s genetic vulnerabilities

Two cancer geneticists make the case for moving beyond tumor sequencing studies.Read more

News / 02.26.21

Computational study finds ways to optimize COVID-19 pooled testing strategies

Mathematical model suggests pooled testing could identify up to 20 times more COVID-19 infections per day than individual testingRead more

News / 02.25.21

Redirected enzymes may open doors to novel therapeutics

By engineering proteins called proteases to find new targets with high selectivity, researchers mark a critical advance toward potential new treatments for a wide range of conditionsRead more